• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Rimtuzalcap

CAS No. 2167246-24-2

Rimtuzalcap ( CAD-1883 )

产品货号. M28737 CAS No. 2167246-24-2

Rimtuzalcap (CAD-1883) 是一种一流的小电导钙激活钾通道(SK 通道)选择性正变构调节剂。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥673 有现货
10MG ¥1064 有现货
25MG ¥2111 有现货
50MG ¥3134 有现货
100MG ¥4248 有现货
200MG ¥5733 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥567 有现货

生物学信息

  • 产品名称
    Rimtuzalcap
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Rimtuzalcap (CAD-1883) 是一种一流的小电导钙激活钾通道(SK 通道)选择性正变构调节剂。
  • 产品描述
    Rimtuzalcap (CAD-1883) is a first-in-class selective positive allosteric modulator of small-conductance calcium-activated potassium channels (SK channels). Rimtuzalcap can be used for the research of movement disorders including essential tremor (ET) and spinocerebellar ataxia (SCA).(In Vitro):Rimtuzalcap (Compound 1) is a small molecule modulator of potassium ion channels showing great therapeutic potential for treating a variety of diseases characterized by dysfunction of potassium ion channels and dysfunction from other causes which influence these potassium channels.(In Vivo):Rimtuzalcap (CAD-1883) reduces the firing rate of Purkinje cells by approximately 40%, consistent with the anticipated therapeutic mechanism of positive allosteric modulation of SK channels. Sequential bath application of 1 or 3 μM CAD-1883 results in a partial reversal of the increased coefficient of variation of the interspike interval which is seen in cerebellar slices from 11-month-old spinocerebellar ataxia-2 58Q mice.
  • 体外实验
    Rimtuzalcap (Compound 1) is a small molecule modulator of potassium ion channels showing great therapeutic potential for treating a variety of diseases characterized by dysfunction of potassium ion channels and dysfunction from other causes which influence these potassium channels.
  • 体内实验
    Rimtuzalcap (CAD-1883) reduces the firing rate of Purkinje cells by approximately 40%, consistent with the anticipated therapeutic mechanism of positive allosteric modulation of SK channels. Sequential bath application of 1 or 3 μM CAD-1883 results in a partial reversal of the increased coefficient of variation of the interspike interval which is seen in cerebellar slices from 11-month-old spinocerebellar ataxia-2 58Q mice.
  • 同义词
    CAD-1883
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    Potassium Channel
  • 受体
    human glucagon receptor
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2167246-24-2
  • 分子量
    378.428
  • 分子式
    C18H24F2N6O
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 250 mg/mL (660.64 mM)
  • SMILES
    Cc1ccn(n1)-c1nc(NC2CCC(F)(F)CC2)cc(n1)N1CCOCC1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.M A Cascieri, et al. Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor. J Biol Chem. 1999 Mar 26;274(13):8694-7.
产品手册
关联产品
  • Linopirdine

    Linopirdine (DUP-996;Linopirine) 是一种有效的 Kv7 (KCNQ) 电压门控钾通道阻滞剂;阻断 KV7.1+7.3 (KCNQ2+3)/M 电流 (IC50=4-7 uM) 和 KV7.1 (KCNQ1) 同聚通道 (IC50=8.9 uM)。

  • Tolazamide

    Tolazamide 是一种口服降血糖药,用于 2 型糖尿病患者。

  • PAP-1

    PAP-1 是一种选择性、口服活性的 Kv1.3 阻滞剂 (EC50: 2 nM)。